NCT04299581View on ClinicalTrials.gov

Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 7, 2020

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2026

Conditions
Intrahepatic Cholangiocarcinoma
Interventions
DRUG

Camrelizumab

a PD-1 immune check inhibitor

COMBINATION_PRODUCT

US/CT-guided Percutaneous Cryoablation

Cryoablation will be performed with a two-cycle freeze-thaw phase protocol; US or non-contrast CT images will be obtained to visualize the evolving ablation zone

Trial Locations (1)

Unknown

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER